BALA CYNWYD, Pa., Sept. 24, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
Werewolf Therapeutics, Inc. (Nasdaq – HOWL)
Under the terms of the Merger Agreement, Werewolf Therapeutics will be acquired by Ambros Therapeutics, Inc. Werewolf Therapeutics stockholders are expected to own approximately 6.8% of the combined company, and Ambros Therapeutics stockholders are expected to own approximately 71.7% of the combined company. The investigation concerns whether the Werewolf Therapeutics Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the proposed transaction is paying fair value to shareholders of the Company.
Additional information can be found at https://www.brodskysmith.com/cases/werewolf-therapeutics-inc-nasdaq-howl/.
Beazer Homes USA, Inc. (NYSE – BZH)
Under the terms of the Merger Agreement, Beazer will be acquired by Dream Finders Homes, Inc. (NYSE - DFH) for $33.50 for each share of Beazer common stock in an all-cash transaction at an enterprise value of approximately $2.2 billion. The investigation concerns whether the Bowman Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the proposed transaction is paying fair value to shareholders of the Company.
Additional information can be found at https://www.brodskysmith.com/cases/beazer-homes-usa-inc-nyse-bzh/.
Lantheus Holdings Inc. (Nasdaq – LNTH)
Under the terms of the Merger Agreement, Lantheus Holdings will be acquired by Curium for $102.50 per share in cash at closing, plus non-transferable Contingent Value Rights (“CVRs”) providing for up to $12.00 per share in potential additional cash payments. The transaction represents a total per share consideration of up to $114.50 and a total transaction value of up to approximately $8.0 billion. The investigation concerns whether the Lantheus Holdings Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the proposed transaction is paying fair value to shareholders of the Company.
Additional information can be found at https://www.brodskysmith.com/cases/lantheus-holdings-inc-nasdaq-lnth/.
MarketAxess Holdings Inc. (Nasdaq – MKTX)
Under the terms of the Merger Agreement, MarketAxess Holdings will be acquired by Intercontinental Exchange, Inc. (NYSE - ICE) for $167 per share in cash, representing an equity value of approximately $6.0 billion and a total enterprise value of approximately $5.7 billion. The investigation concerns whether the MarketAxess Holdings Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the proposed transaction is paying fair value to shareholders of the Company.
Additional information can be found at https://www.brodskysmith.com/cases/marketaxess-holdings-inc-nasdaq-mktx/.
Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.
